Expression Therapeutics Inc., a clinical-stage biopharmaceutical company developing next-generation cellular therapies, has appointed David F. Townson, Ph.D., as Chief Executive Officer, effective immediately. Townson brings extensive executive leadership experience from premier pharmaceutical organizations and a proven track record of advancing transformative oncology and cell therapy programs from development through global commercialization. “David’s appointment represents a...